Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy

Clinical Endocrinology

Volumn 59, Issue 6, 2003, Pages 788-792

  Carvalho, Luciani R ^a   De Faria, Maria Estela Justamante ^b   Farah Osorio, Maria Geralda ^a   Estefan, Vivian ^a   Lima Jorge, Alexander Augusto ^a   Prado Arnhold, Ivo Jorge ^a   Mendonca, Berenice Bilharinho ^a,b  

^a Lab Hormonios Genet Molec D   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; BODY GROWTH; BONE AGE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; FOOT; GROWTH HORMONE DEFICIENCY; HAND; HORMONE RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; JAW; MALE; PATIENT CODING; PRIORITY JOURNAL;

ACROMEGALY; ADOLESCENT; ANTHROPOMETRY; CHILD; DWARFISM, PITUITARY; FEMALE; FOOT DISEASES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PITUITARY HORMONES; TIME FACTORS;

EID: 0345376016     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01899.x     Document Type: Article

References (16)

1. Chen, Y.D., Shu, S.G. & Chi, C.S. (2001) Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone. Acta Paediatrica Taiwan, 42, 291-296.
2. Gerver, W.J.M. & de Bruin R. (2001) Pediatric Morphometrics: A Reference Manual, 2nd edn. University Pers Maastricht, Pers Maastricht.
3. Greulich, W.N. & Pyle S.I. (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edition. Stanford, CA, USA, Stanford University Press.
4. Guyda, H.J. (1997) How do we best measure growth hormone action? Hormone Research, 48 (Suppl. 5), 1-10.
5. Martins, D.R., Janson, G.R.P., Almeida, R.R., Pinzan, A., Henriques, J.F.C. & Freitas, M.R. (1998) Atlas de crescimento craniofacial. Santos, Sao Paolo.
6. Mauras, N., Attie, K.M., Reiter, E.O., Saenger, P. & Baptista, J. (2000) High-dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc. Cooperative Study Group. Journal of Clinical Endocrinology and Metabolism, 85, 3653-3660.
7. Myers, S.E. (1999) Prader Willi syndrome: a brigther future ahead. GH and growth factors in endocrinology and metabolism. Pharmacia Upjohn, 27th International Symposium, Nice.
8. Riolo, M.L., Moyers, R.E., McNamara, J.A. & Hunter, W.S. (1974) An Atlas of Craniofacial Growth: Center of Human Growth and Development, University of Michigan.
9. Rosenfeld, R.G., Albertsson-Wikland, K., Cassorla, F., Frosier, S.D., Hasegawa, Y., Hintz, R.L., Lafranchi, S., Lippe, B., Loriaux, L. & Melmed, S. et al. (1995) Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. Journal of Clinical Endocrinology and Metabolism, 80, 1532-1540.
10. Sas, T.C., Gerver, W.J., de Bruin, R., Stijnen, T., de Muinck Keizer-Schrama, S.M., Cole, T.J., van Teunenbroek, A. & Drop, S.L. (1999) Body proportions during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response trial. Journal of Clinical Endocrinology and Metabolism, 84, 4622-4628.
11. Silva, E.G., Slhessarenko, N., Arnhold, I.J., Batista, M.C., Estefan, V., Osorio, M.G., Marui, S. & Mendonca, B.B. (2003) GH values after clonidine stimulation measured by immunofluorometric assay in normal prepubertal children and GH-deficient patients. Hormone Research, 59, 229-233.
12. Simmons, K.E. (1999) Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome. Pediatrics, 104 (4 Part 2), 1021-1024.
13. Tanner, J.M. & Whitehouse, R.H. (1976) Standfords from birth to maturity for height, weight, height velocity and weight velocity: British children. Archives of Disease in Childhood, 51, 170.
14. Thomas, M., Massa, G., Bourguignon, J.P., Craen, M., De Schepper, J., de Zegher, F., Dooms, L., Du Caju, M., Francois, I., Heinrichs, C., Malvaux, P., Rooman, R., Thiry-Counson, G., Vandeweghe, M. & Maes, M. (2001) Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: the Belgian experience. Hormone Research, 55, 88-94.
15. Underwood, L.E., Backeljauw, P. & Duncan, V. & the Growth Hormone-Insensitive Group. (1999) Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. Acta Paediatrica Supplement, 88, 182-184.
16. Wit, J.M., Rekers-Mombarg, L.T. & Dutch Growth Hormone Advisory Group. (2002) Final height gain by GH therapy in children with idiopathic short stature is dose dependent. Journal of Clinical Endocrinology and Metabolism, 87, 604-611.